Applied Molecular Evolution, Inc.
Records under this name other than the patents Applied Molecular Evolution, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Back to Applied Molecular Evolution, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,340,613 | Anti-IL-6 Antibodies, Compositions, Methods and Uses now held by Janssen Biotech, Inc. Term ended Term ended Aug 16, 2026 · High confidence | Term ended | Term ended Aug 16, 2026 | High confidence |
| US 11,180,549 | Methods of Suppressing Rheumatoid Arthritis Using an Anti-IL-6 Antibody Term ended Term ended Apr 28, 2026 · High confidence | Term ended | Term ended Apr 28, 2026 | High confidence |
| US 7,541,033 | Humanized ANTI-IL-1 Beta Antibodies now held by Eli Lilly and Company Term ended Term ended Feb 5, 2026 · High confidence | Term ended | Term ended Feb 5, 2026 | High confidence |
| US 7,740,847 | Variant FC Regions now held by Mentrik Biotech, LLC Term ended Term ended Jan 29, 2026 · High confidence | Term ended | Term ended Jan 29, 2026 | High confidence |
| US 7,101,978 | Tnf-Alpha Binding Molecules now held by Trimer Biotech, LLC Term ended Term ended Dec 13, 2024 · High confidence | Term ended | Term ended Dec 13, 2024 | High confidence |
| US 8,153,125 | CD20 Binding Molecules Lapsed on the fee record Ended Apr 10, 2024 · High confidence | Lapsed on the fee record | Ended Apr 10, 2024 | High confidence |
| US 7,714,120 | Humanized ANTI-IL-1 Beta Antibodies now held by Eli Lilly and Company Term ended Term ended Jan 21, 2024 · High confidence | Term ended | Term ended Jan 21, 2024 | High confidence |
| US 7,575,747 | A¿ Binding Molecules Lapsed on the fee record Ended Aug 18, 2021 · High confidence | Lapsed on the fee record | Ended Aug 18, 2021 | High confidence |
| US 7,700,735 | High Potency Recombinant Antibodies and Method for Producing Them now held by MedImmune, LLC Term ended Term ended Aug 10, 2021 · High confidence | Term ended | Term ended Aug 10, 2021 | High confidence |
| US 6,818,216 | Methods of Administering/Dosing Anti-Rsv Antibodies for Prophylaxis and Treatment now held by MedImmune, LLC Term ended Term ended Nov 28, 2020 · Medium confidence | Term ended | Term ended Nov 28, 2020 | Medium confidence |